Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PSC-833/VAD vs VAD in Relapsing or Refractory Multiple Myeloma
NCT00002878Phase 3Completed
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- Jun 1997
- Primary completion
- Apr 2003
- Modality
- Peptides, Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of valspodar in multiple myeloma (MM), sponsored by Eastern Cooperative Oncology Group. Started Jun 1997; status: completed.
02
Drugs
valspodar
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00002878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002878.